DHG expands growth momentum

DHG expands growth momentum

Leveraging sustainable development and a flexible strategy, DHG Pharmaceutical JSC has made a spectacular breakthrough in recent times, serving as a strong basis for the next growth step.
Pharma firms expect hike in revenue thanks to COVID-19

Pharma firms expect hike in revenue thanks to COVID-19

Taking advantages of the COVID-19 lockdown, major pharma firms hope to get growth in revenue this year.
DHG keeps throne by continuous innovation to create new values

DHG keeps throne by continuous innovation to create new values

Being the sole company to score a hat-trick at the 2019 Listed Enterprise Award with more excellent achievements than last year, DHG Pharmaceutical JSC (DHG) has grown from strength to strength, with deeper co-operation with Japanese strategic partner Taisho Pharmaceutical Co., Ltd.
Taisho spends $110 million on controlling stake in DHG

Taisho spends $110 million on controlling stake in DHG

Taisho Group now officially holds a controlling stake in DHG after spending VND2.47 trillion ($107.4 million) on buying 20.6 million DHG shares.
Pharma firms look to future

Pharma firms look to future

With expected fierce rivalry as a result of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership, domestic Vietnamese pharmaceutical businesses are increasingly investing big in technological innovations that help them stay competitive in a lucrative market.
Competition intensifies in pharmaceutical sector

Competition intensifies in pharmaceutical sector

After a tough 12 months, competition in Vietnam’s lucrative pharmaceutical industry is forecast to heat up in 2019..
Taisho still looking to increase stake in DHG

Taisho still looking to increase stake in DHG

Taisho Group, one of the largest five pharmaceutical firms in Japan, expressed interest in buying an additional 2.3 per cent (3 million shares) in DHG.
Hand-shakes between local and foreign players in pharmaceutical market

Hand-shakes between local and foreign players in pharmaceutical market

Growing participation of foreign players in Vietnam’s pharmaceutical market is putting pressures on local pharmaceutical firms, however analysts suggest the deals with foreign partners could bring certain benefits to their local partners.  
Taisho offers to purchase DHG shares

Taisho offers to purchase DHG shares

Japanese pharmaceutical firm Taisho has offered to buy more than 9.23 million shares of DHG Pharmaceutical JSC (DHG), 7.06 per cent of DHG’s total shares.
Taisho inches towards domination at DHG

Taisho inches towards domination at DHG

Taisho Group registered to buy an additional 7.06 per cent (9.2 million shares) in DHG as the next step in its plan to step-by-step acquire the drug maker.
DHG approved to abolish FOL

DHG approved to abolish FOL

DHG has recently been approved to lift the foreign ownership limit (FOL) to 100 per cent, according to information published on its website.
DHG to abolish FOL

DHG to abolish FOL

Hau Giang Pharmaceutical JSC will remove the foreign ownership limit to welcome old and new investors looking for its shares.
Taisho Group increases holding in Hau Giang Pharmaceutical

Taisho Group increases holding in Hau Giang Pharmaceutical

Taisho Group expressed interest in buying an additional 650,000 shares to increase its holding in Hau Giang Pharmaceutical JSC (DHG) to 24.94 per cent.
DHG's profit falls in first quarter, challenges posed by FOL removal

DHG's profit falls in first quarter, challenges posed by FOL removal

Vietnam’s biggest publicly-traded drug maker Hau Giang Pharmaceutical JSC (DHG) saw a slight fall of 4.4 per cent on-year in its first quarter gross profit.